George Sing

George Sing

Director/Board Member at REGENERON PHARMACEUTICALS, INC.

Net worth: 27 M $ as of 2024-03-30

74 year
Health Technology
Finance
Consumer Services

Profile

George L.
Sing
was the founder of Merrill Lynch Ventures LLC, Noveome Biotherapeutics, Inc., ATV Capital Management Inc., Merrill Lynch Venture Capital, Inc., and Lancet Capital Partners LLC.
He is currently the Chief Executive Officer at GanD, Inc. since 2016, Chairman at Grace Science LLC since 2017, and an Independent Director at Regeneron Pharmaceuticals, Inc. since 1988.
His former position includes being a Director at VivoQuest, Inc. He holds an MBA from Harvard Business School and an undergraduate degree from Stevens Institute of Technology.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-25 28,499 ( 0.03% ) 27 M $ 2024-03-30

George Sing active positions

CompaniesPositionStart
REGENERON PHARMACEUTICALS, INC. Director/Board Member 1988-01-07
Founder -
GanD, Inc. Chief Executive Officer 2015-12-31
Grace Science LLC Chairman 2016-12-31
All active positions of George Sing

Former positions of George Sing

CompaniesPositionEnd
Founder -
Merrill Lynch Venture Capital, Inc. Founder -
Director/Board Member -
Founder -
Founder -
See the detail of George Sing's experience

Training of George Sing

Stevens Institute of Technology Undergraduate Degree
Harvard Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of George Sing's experience

Connections

83

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
REGENERON PHARMACEUTICALS, INC.

Health Technology

Private companies8

Finance

Finance

Health Technology

Merrill Lynch Venture Capital, Inc.

Health Technology

Finance

Grace Science LLC

GanD, Inc.

See company connections